Back to Search
Start Over
Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan
- Source :
- Emerging Infectious Diseases. July, 2022, Vol. 28 Issue 7, p1518, 3 p.
- Publication Year :
- 2022
-
Abstract
- In response to the COVID-19 pandemic, mRNA-based SARS-CoV-2 vaccination has spread rapidly worldwide. This vaccine has shown high efficacy for preventing infection and disease exacerbation. However, adverse immunologic effects, including [...]
- Subjects :
- Type 1 diabetes -- Case studies -- Causes of -- Risk factors
Health
Subjects
Details
- Language :
- English
- ISSN :
- 10806040
- Volume :
- 28
- Issue :
- 7
- Database :
- Gale General OneFile
- Journal :
- Emerging Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.709976813
- Full Text :
- https://doi.org/10.3201/eid2807.220127